Eighteenfiftynine Company
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Headquarters:
San Diego, California, United States
Last Funding Date:
2022-02-07
Total Funding:
52200000.0
Last Funding Type:
Series A
Founded Date:
2019-01-01
Investors Number:
4.0
Industry:
Early Drug Development